G
Gláucia Fernandes Cota
Researcher at Oswaldo Cruz Foundation
Publications - 63
Citations - 1371
Gláucia Fernandes Cota is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Visceral leishmaniasis & Medicine. The author has an hindex of 17, co-authored 53 publications receiving 1081 citations. Previous affiliations of Gláucia Fernandes Cota include Universidade Federal de Minas Gerais.
Papers
More filters
Journal ArticleDOI
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.
TL;DR: A systematic literature review with indirect comparison of studies evaluating therapeutic efficacy and toxicity associated to visceral leishmaniasis (VL) therapy among HIV infected individuals suggests that amphotericin is superior to antimony treatment.
Journal ArticleDOI
Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.
TL;DR: A systematic review of previous studies that have described predictors of VL relapse in HIV-infected patients found that the absence of an increase in CD4+ cells at follow-up; a) lack of secondary prophylaxis; and c) previous history of Vl relapse could be identified.
Journal ArticleDOI
The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis.
TL;DR: Based mainly on evidence gained by infection with Leishmania infantum chagasi, serological tests should not be used to rule out a diagnosis of VL among the HIV-infected, but a positive test at even low titers has diagnostic value when combined with the clinical case definition.
Journal ArticleDOI
Visceral Leishmaniasis and HIV Coinfection in Latin America
José Angelo Lauletta Lindoso,Gláucia Fernandes Cota,Alda Maria da Cruz,Hiro Goto,Ana Nilce Silveira Maia-Elkhoury,Gustavo Adolfo Sierra Romero,Marcia Leite de Sousa-Gomes,Joanna Reis Santos-Oliveira,Ana Rabello +8 more
TL;DR: The formation of a Latin American network for coinfections of Leishmania and HIV to improve the consistency of research on the current situation of VL-HIV coinfection is strongly supported.
Journal ArticleDOI
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
TL;DR: It was determined that patients submitted to IL-Sbv treatments longer than 14 days had higher cure rates and an indirect comparison shows that the antimony infiltration efficacy rate is similar to that reported for antimony systemic use.